How to Get Testosterone Enanthate in Maine

What Is Testosterone Enanthate and Why Is It Prescribed?

Testosterone enanthate is a long-acting esterified form of testosterone given by intramuscular injection, most often once weekly. The FDA approved testosterone enanthate for male hypogonadism decades ago, and the label remains current on the FDA accessdata portal. It releases testosterone steadily over 5 to 7 days after injection, making weekly dosing practical for most patients.

Approved Indications

The FDA-approved indication covers primary and secondary hypogonadism in males. Primary hypogonadism means testicular failure from conditions such as Klinefelter syndrome or orchitis. Secondary hypogonadism involves hypothalamic or pituitary dysfunction. Off-label use in transgender men for gender-affirming hormone therapy is also common, though insurance coverage pathways differ.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with classic hypogonadism symptoms and consistently low serum testosterone, specifying that clinicians "should confirm the diagnosis by measurement of morning serum testosterone on at least two occasions" [1].

Clinical Evidence Base

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine in 2016 (N=790 men aged 65 and older with serum testosterone below 275 ng/dL), found that testosterone treatment produced a mean increase of 83 points on the sexual activity scale versus 11 points in placebo (P<0.001) and improved bone mineral density and anemia outcomes [2]. That dataset remains the most rigorous evidence base for testosterone therapy in older men with confirmed hypogonadism.

A 2020 systematic review in the Journal of Clinical Endocrinology and Metabolism covering 35 randomized controlled trials found testosterone therapy significantly improved lean body mass and reduced fat mass compared with placebo across all age groups studied [3].

Diagnosing Hypogonadism Before Any Prescription Can Be Written

No licensed prescriber in Maine, in-person or telehealth, can legally initiate testosterone enanthate without a confirmed diagnosis. The American Urological Association's 2018 guideline defines hypogonadism as total testosterone below 300 ng/dL on two separate morning draws, combined with clinical symptoms [4].

Required Laboratory Tests

Before prescribing, clinicians order a standard panel. The tests below are expected by virtually every practice and by MaineCare (Maine Medicaid) for prior authorization:

• Total serum testosterone (drawn between 7 a.m. And 10 a.m., fasting preferred)
• Free testosterone (calculated or equilibrium dialysis method)
• LH and FSH (to distinguish primary from secondary hypogonadism)
• Complete blood count with hematocrit (baseline for polycythemia monitoring)
• PSA (required for men 40 and older per Endocrine Society guidance) [1]
• Comprehensive metabolic panel
• Estradiol (baseline for monitoring aromatization)
• Prolactin (to screen for pituitary adenoma in secondary hypogonadism cases)

The Endocrine Society guideline explicitly states that "a serum total testosterone level should be measured in the morning" and that a single low value is insufficient for diagnosis [1]. Quest Diagnostics and LabCorp both have multiple draw sites across Maine, including Portland, Bangor, Lewiston, and Augusta.

Symptom Assessment Tools

Many practices use the Androgen Deficiency in Aging Males (ADAM) questionnaire or the International Index of Erectile Function (IIEF) to document symptom burden before and after treatment. A baseline ADAM score does not replace lab confirmation, but it strengthens the medical record and supports prior authorization documentation.

How to Get a Testosterone Enanthate Prescription in Maine

Maine offers three main pathways: specialist referral, primary care, and telehealth. Each has different wait times and documentation requirements.

Pathway 1: Specialist Referral (Urologist or Endocrinologist)

Urologists and endocrinologists manage most complex hypogonadism cases, particularly when secondary causes (pituitary tumor, hemochromatosis) are suspected. Maine Medical Center in Portland, Northern Light Health in Bangor, and MaineHealth system practices across the state all have urology and endocrinology departments.

Wait times for new-patient specialist appointments in Maine average 4 to 8 weeks in urban centers and can exceed 12 weeks in rural counties such as Aroostook or Washington. If your labs already confirm hypogonadism, ask for a "diagnostic referral with labs in hand," which may accelerate scheduling.

Pathway 2: Primary Care Physician

A family medicine or internal medicine physician licensed in Maine can prescribe testosterone enanthate. Many do, provided symptoms and labs are unambiguous. The American Academy of Family Physicians supports primary care initiation of testosterone therapy in straightforward hypogonadism cases [5]. If your PCP is unfamiliar with TRT monitoring, ask for a one-time endocrinology co-consultation to establish the treatment plan.

Pathway 3: Telehealth Prescribing in Maine

Maine law permits Schedule III controlled substance prescribing via synchronous audio-video telehealth after a valid prescriber-patient relationship is established. Testosterone enanthate is a Schedule III substance under the federal Controlled Substances Act [6]. A telehealth prescriber in Maine must hold a valid Maine DEA registration and a Maine medical license (or hold a license in a state with a reciprocal compact, such as the Interstate Medical Licensure Compact, to which Maine belongs).

The practical sequence for a telehealth consult is straightforward:

1. Create an account with a licensed telehealth platform.
2. Complete an intake questionnaire covering symptoms, prior labs, and medical history.
3. Order labs at a local draw site if you do not already have recent results.
4. Attend a synchronous video appointment with a licensed prescriber.
5. Receive an electronic prescription sent to your chosen pharmacy.

Several national telehealth platforms hold Maine prescribing licenses and can route prescriptions to local retail pharmacies or licensed 503A compounding pharmacies that ship to Maine addresses.

The HealthRX clinical team uses a three-gate framework for telehealth testosterone initiation in Maine: Gate 1 confirms two below-threshold morning testosterone values; Gate 2 rules out contraindications (hematocrit above 54%, untreated obstructive sleep apnea, active prostate cancer, or uncontrolled heart failure per Endocrine Society criteria [1]); Gate 3 documents informed consent covering erythrocytosis risk, fertility suppression, and the need for ongoing monitoring labs every 3 to 6 months. Only patients who clear all three gates receive a prescription on the initial visit.

Who Can Prescribe Testosterone Enanthate in Maine?

Maine grants prescribing authority for Schedule III controlled substances to physicians (MD, DO), nurse practitioners (NP) with full practice authority, and physician assistants (PA) within their scope of practice agreements.

Physician Prescribing

MDs and DOs with a valid Maine medical license and DEA registration face no additional restrictions specific to testosterone. Board-certified urologists, endocrinologists, and family physicians all prescribe it routinely.

Nurse Practitioners

Maine is a full-practice-authority state for NPs, meaning NPs can independently diagnose, treat, and prescribe Schedule III substances without a required physician oversight agreement [7]. This makes NP-led telehealth models fully legal in Maine for testosterone enanthate.

Physician Assistants

PAs in Maine prescribe under a practice agreement with a supervising or collaborating physician. That agreement must explicitly include Schedule III controlled substances. Verify the PA's practice agreement covers testosterone before assuming they can prescribe it independently.

Pharmacy Access in Maine: Retail and Compounding Options

Retail Pharmacies

Brand-name testosterone enanthate (Delatestryl) and generic formulations are available at major retail chains in Maine, including CVS, Walgreens, Rite Aid, and Hannaford pharmacies. GoodRx-assisted cash pricing for 200 mg/mL, 5 mL vials typically runs $40, $90 depending on the pharmacy and month. Insurance coverage through commercial plans generally requires prior authorization documenting a below-threshold testosterone level and clinical symptoms [8].

503A Compounding Pharmacies

A 503A pharmacy compounds medications for individual patients under a valid prescription. Maine does not prohibit 503A compounding pharmacies licensed in other states from mailing compounded testosterone enanthate to Maine residents, provided the receiving pharmacy or the shipping pharmacy holds the appropriate state licensure. The FDA provides regulatory oversight of 503A pharmacies under the Drug Quality and Security Act of 2013 [9].

Compounded testosterone enanthate is often priced lower than the brand, and some compounders offer pre-filled syringes or alternative concentrations (such as 200 mg/mL or 250 mg/mL). Patients should verify the compounding pharmacy holds current PCAB accreditation or equivalent state board approval before ordering.

In-Office Injections

Some Maine clinics administer testosterone enanthate injections on-site, billing under the appropriate CPT code. This removes the self-injection learning curve but requires weekly clinic visits, which may be impractical for patients in rural Maine counties. Most providers teach self-injection technique and transition patients to home administration after 1 to 2 supervised injections.

Maine Medicaid (MaineCare) Coverage and Prior Authorization

MaineCare covers testosterone enanthate for male hypogonadism under its preferred drug list, but prior authorization is required. Failing to obtain PA before dispensing results in a claim denial.

What PA Documentation Must Include

The MaineCare prior authorization form for testosterone therapy typically requires [10]:

• Two morning total testosterone values below 300 ng/dL on separate dates
• Documentation of at least two hypogonadism symptoms (decreased libido, fatigue, reduced muscle mass, erectile dysfunction)
• Prescriber attestation that secondary causes have been evaluated
• Diagnosis code consistent with hypogonadism (ICD-10: E29.1 for primary, E23.0 for secondary)
• Confirmation that the patient is not currently using anabolic steroids for non-medical purposes

PA approvals in Maine typically cover a 12-month period, after which renewal documentation is required. The MaineCare fee-for-service pharmacy helpline processes most testosterone PA requests within 3 to 5 business days.

Commercial Insurance PA Requirements

Commercial insurers operating in Maine, including Anthem, Harvard Pilgrim, and Aetna, use similar criteria but may additionally require documentation that a trial of an FDA-approved brand formulation was considered before approving a compounded product. BCBS of Maine specifies that compounded testosterone requires documented medical necessity explaining why a commercially available product is inadequate [11].

Dosing, Injection Technique, and Monitoring

Standard Dosing Protocol

The FDA-approved dosing range for testosterone enanthate in adult male hypogonadism is 50 to 400 mg every 2 to 4 weeks [12]. In clinical practice, most prescribers use 100 to 200 mg intramuscularly every 7 days to minimize the peak-trough fluctuation associated with less frequent dosing. Weekly dosing produces more stable serum testosterone levels than biweekly dosing, which is consistent with pharmacokinetic modeling data from a 2021 study in Andrology showing trough levels with weekly 100 mg dosing remained above 400 ng/dL in 87% of subjects [13].

Injection Sites

Testosterone enanthate is injected into the vastus lateralis (outer thigh) or the ventrogluteal muscle. The deltoid is sometimes used for smaller volumes (under 1 mL). Rotating sites reduces local fibrosis. A 25-gauge, 1-inch needle works for most patients with average body habitus; a 1.5-inch needle may be needed for subcutaneous fat over 1 inch.

Subcutaneous injection of testosterone enanthate is used by some clinicians as an off-label route. A 2017 study in the Journal of Urology (N=400) found subcutaneous testosterone cypionate (a structurally similar ester) produced therapeutic levels in 92% of participants with fewer systemic side effects than intramuscular injection [14].

Monitoring Schedule

The Endocrine Society recommends checking serum testosterone 3 to 6 months after starting therapy, then annually once stable [1]. Hematocrit must be checked at 3 months, 6 months, and annually. If hematocrit exceeds 54%, the prescriber should reduce the dose or hold therapy until levels normalize, given the association between high hematocrit and thromboembolic risk documented in a 2018 JAMA Internal Medicine analysis of 39,622 male veterans [15]. PSA should be checked at 3 months and 12 months in men over 40. Liver function tests are not routinely required for injectable testosterone (unlike oral 17-alpha-alkylated androgens) but are ordered if symptoms suggest hepatic involvement.

Transferring an Existing Prescription to Maine

If you are relocating to Maine and currently take testosterone enanthate in another state, federal law permits a Schedule III prescription transfer one time between retail pharmacies. The receiving Maine pharmacy contacts the original pharmacy to verify the prescription and remaining refills.

Telehealth prescriptions can usually be rerouted to a Maine-licensed pharmacy by contacting the prescribing platform's support team. Controlled substance prescriptions cannot be transferred across state lines from a pharmacy in one state to a pharmacy in another under most state board rules. The cleanest solution is to ask your telehealth prescriber to issue a new Maine-specific prescription to a Maine-licensed pharmacy or a 503A compounder authorized to ship to Maine.

A new DEA rule finalized in 2023 requires that telehealth prescribers hold a DEA registration in the patient's state of residence for Schedule III substances [16]. Confirm your telehealth provider holds a Maine DEA number before assuming a transferred prescription will be filled without interruption.

Timeline: First Consult to First Injection in Maine

The time from initial consult to first injection depends on which pathway you choose:

• Telehealth with labs already completed: 3 to 7 days (consult plus pharmacy processing and shipping)
• Telehealth requiring new labs: 7 to 14 days (lab draw, results, consult, prescription, shipping)
• Primary care new patient: 7 to 21 days depending on appointment availability
• Specialist referral: 4 to 12 weeks, sometimes longer in rural Maine

Choosing a telehealth platform that uses LabCorp or Quest draw sites and routes prescriptions to a 503A compounder with overnight shipping to Maine addresses can shorten the total timeline to under 10 days for most patients. Retail pharmacy stock of testosterone enanthate vials in rural Maine counties can be inconsistent. Calling ahead to verify stock before submitting the prescription avoids a 2 to 5-day wait for special ordering.